Fulvestrant (Faslodex®) was synthesized in four steps (35% overall yield) from 6-dehydronandrolone acetate. Catalyst controlled, room temperature, diastereoselective 1,6-addition of the zirconocene derived from commercially available 9-bromonon-1-ene was used in the key C-C bond forming step.
An alternative synthesis of the breast cancer drug fulvestrant (Faslodex®): catalyst control over C-C bond formation
Caprioglio D.Primo
;
2015-01-01
Abstract
Fulvestrant (Faslodex®) was synthesized in four steps (35% overall yield) from 6-dehydronandrolone acetate. Catalyst controlled, room temperature, diastereoselective 1,6-addition of the zirconocene derived from commercially available 9-bromonon-1-ene was used in the key C-C bond forming step.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
c5cc05805h.pdf
file disponibile solo agli amministratori
Tipologia:
Documento in Post-print
Licenza:
DRM non definito
Dimensione
1.41 MB
Formato
Adobe PDF
|
1.41 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
